Residents and Fellows Research in Progress
Tuesday, October 15, 2024
08:30 AM–10:00 AM
Abstract
Introduction: Avoidance of significant glucose excursions, especially hypoglycemia, is a priority at diabetes camps, and insulin dose reductions are common practice. However, standardized guidance for empiric adjustments to diabetes management regimens in the summer camp setting has yet to be established.
Research Question or Hypothesis: What effect does the magnitude of daily basal insulin dose reduction have on glycemic control at a pediatric diabetes camp?
Study Design: Retrospective cohort study of subjects attending Camp New Day, a week-long, residential pediatric diabetes camp, between June 2022 and July 2023.
Methods: Campers with type 1 diabetes were included if they attended an entire week of camp. The primary outcome was the rate of normoglycemia for specified percentages of daily basal insulin dose reductions. Baseline characteristics and outcome data were collected using Microsoft Excel via manual chart review. Insulin doses recorded on the first day of camp represent baseline insulin doses, informed by camp intake forms. Normoglycemia is defined as blood glucose between 80 mg/dL and 350 mg/dL. Daily insulin doses and blood glucose control were evaluated. Results are evaluated using descriptive statistics.
Results: The 159 campers included in the study were 58% female, 12 years old on average, with a mean HbA1c of 8.5%, and 61% utilized insulin pumps. Nine and twenty-eight hybrid closed loop (HCL) insulin pumps were utilized in 2022 and 2023, respectively. The highest daily rate of normoglycemia occurred in campers with a reduction of basal insulin between 1 and 10% on Thursday (70%). Overall, campers whose basal insulin was decreased by 11-20% had the most normoglycemia (51%). Campers with basal insulin dose reductions between 21-30% experienced the least normoglycemia (22%).
Conclusion: An empiric daily basal insulin dose reduction between 1 and 20% may be appropriate at diabetes camps. Utilization of HCL insulin pumps is increasing. Our study may inform additional research on optimal glycemic management at diabetes camps.
Presenting Author
Lindy Burnam Pharm. D.Texas Tech Univeristy Health Sciences Center Jerry H. Hodge School of Pharmacy
Authors
Sofia Martinez Pharm.D. Candidate
Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy
Thomas Parker Pharm. D., CDCES
Texas Tech University Health Sciences Center Jerry H. Hodge School of Pharmacy